Skip to content
A portrait of Kim Lewis
Kim Lewis
University Distinguished Professor of Biology, Director of Antimicrobial Discovery Center

Kim Lewis in the Press

Kim Lewis for Northeastern Global News

The exterior of an academic building displaying "Northeastern University." Autumnal leaves shine in the foreground.

Twelve Northeastern scholars make ‘Highly Cited Researchers’ list

The faculty were included in this year’s “Highly Cited Researchers” list, scholars who rank among the top 1% of their field.
Robbie Green holding up a large beaker of orange colored substance in a lab.

This antibiotic is effective against anthrax, and has no detectable resistance, Northeastern research finds

“The discovery of teixobactin changed the paradigm in the field of antibiotics,” says Kim Lewis of Northeastern University.
A small screen slide with antibiotic research on it.

Northeastern researcher Kim Lewis develops new approach — using soil bacteria — to help accelerate discovery of new antibiotics

Federally funded project aims to solve the growing problems of antibiotic resistance that contributes to millions of deaths annually
A tick being held up in tweezers.

Experimental antibiotic treatment for Lyme heads for human safety trials

Novel Lyme treatment developed by Northeastern’s Kim Lewis is being screened for toxicity in healthy people during phase 1 trial.
Kim Lewis and Yu Imai in a lab

New antibiotic that could treat drug-resistant infections and superbugs discovered by Northeastern microbiologist in collaboration with NovoBiotic

Kim Lewis worked with NovoBiotic to discover clovibactin, which was isolated from an uncultured soil bacterium. The antibiotic has cleared deadly MRSA in mouse models and shows potential for treating drug-resistant infections.
a tick on a blade of grass under a microscope

Will the new vaccines prevent Lyme disease? And when will they be available? 

Pfizer plans to seek full FDA approval for the new Lyme vaccine VLA15 in 2026, one year later than anticipated. Northeastern experts explain the promise and potential challenges of the shots.

Could ‘new’ antibiotic treatment prevent chronic Lyme disease?

Northeastern researcher Kim Lewis says human trials of a targeted antibiotic for Lyme disease may start next year. The theory is hygromycin A could prevent chronic Lyme by not harming the normal gut microbiome.
A closeup of a very tiny tick (about the size of a pencil tip) on a finger

The teeny, tiny ticks that cause the most Lyme disease are out

The nymphal deer ticks that are out now are less likely to carry the pathogens that cause Lyme disease than the adult ticks, but they are so hard to spot—and therefore remove—they are responsible for most cases of human infection. Prevention is key.

A new antibiotic has been hiding in the gut of a tiny worm. It may be our best weapon against drug-resistant bacteria.

Kim Lewis, University Distinguished Professor of biology, says we are in the midst of a global antibiotic resistance crisis. A new class of antibiotics discovered in his lab could be our best hope against some of the nastiest superbugs out there.

Six Northeastern professors named to list of ‘highly cited researchers’ around the globe

Treating cancer and other diseases in novel ways. Discovering a new antibiotic. Understanding why people become successful. These groundbreaking research achievements are among the accomplishments of six faculty members who have been recognized for the high rate at which their papers have been cited by other researchers.